PHIO
Phio Pharmaceuticals Corp. - Common Stock (PHIO)
$80
About Phio Pharmaceuticals Corp. - Common Stock (PHIO)
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the proprietary INTASYL® small interfering RNA gene silencing technology designed to make immune cells more effective in killing tumor cells. Its pipelines include PH-762 and PH-894. The company was founded on September 8, 2011 and is headquartered in King of Prussia, PA.
Details
Daily high
$0.83
Daily low
$0.75
Price at open
$0.78
52 Week High
$1.88
52 Week Low
$0.75
Market cap
9.3M
Dividend yield
-
Volume
75,622
Avg. volume
66,560
P/E ratio
-.60
Phio Pharmaceuticals Corp. - Common Stock News
Details
Daily high
$0.83
Daily low
$0.75
Price at open
$0.78
52 Week High
$1.88
52 Week Low
$0.75
Market cap
9.3M
Dividend yield
-
Volume
75,622
Avg. volume
66,560
P/E ratio
-.60